RE:RE:Chinese investors are involed - sky rocket soon
On December 7th, 2017, Jenex presented its InterceptCS technology for cold sores and its TherOZap technology, currently being tested to inactivate the Zika virus, at the Chinese Global Financial Forum along with the proposed medical device target acquisitions for acne and other cosmetic applications Read more at https://www.stockhouse.com/news/press-releases/2017/12/12/the-jenex-corporation-announces-graduation-to-the-tsx-venture-update-on-chinese#l7iga22MLXhrHUWS.99 Please read between the lines .... We have to present our results to Chinese investors ... if you have bad news, you will present them to investors ... I have my answer ...